💰 Dividend History

No dividend history available.

📅 Earnings & EPS History for BU

No earnings history available for this symbol.

📰 Related News & Research

• Nutriband Selects Commercial Brand Name for Abuse-Deterrent Fentanyl Patch Using AVERSA Technology
  April 8, 2026
  

  Nutriband Inc. Selects Commercial Brand Name for Abuse-Deter...

• FG Nexus Inc. Board Reviews Potential Business Combination with FG Communities to Accelerate Real-World Asset Tokenization Strategy
  April 8, 2026
  

  FG Nexus Inc. Considers Strategic Alternatives Including Pot...

• XPLR Infrastructure, LP Files SEC Form 8-K for Common Units Distribution Agreement – April 2026
  April 8, 2026
  

  XPLR Infrastructure, LP Files Form 8-K: Key Developments and...

• IQM Quantum Computers and Real Asset Acquisition Corp. Announce Proposed Business Combination to Go Public in 2026
  April 8, 2026
  

  IQM Quantum Computers and Real Asset Acquisition Corp. Annou...

• Thunder Power: Premium Electric Vehicle Manufacturer, Business Strategy, Competitive Risks & Market Expansion Plans
  April 8, 2026
  

  Overview Thunder Power Holdings, Inc. (AIEV), a Delawar...

• Security Bank Annual Report 10-K: Business Overview, Financials, and Key Risk Factors
  April 8, 2026
  

  Security Midwest Bancorp, Inc. 2025 Annual Report - Investor...

• Guangdong Jiayun Technology 2025 Annual Report Summary: Internet Marketing, Beauty Business, Financial Data, and Major Corporate Events
  April 8, 2026
  

  广东佳云科技股份有限公司2025年年度报告详解：聚焦主营优化、亏损缩减及重大资产变动 一、报告核心要点 广东佳云科技...

• Hytera Announces No Profit Distribution for 2025 Due to Losses and Accumulated Deficit
  April 8, 2026
  

  海能达通信股份有限公司2025年度不进行利润分配公告深度解读 海能达通信股份有限公司2025年度不进行利润分配公告深...

• Zhejiang Hisun Pharmaceutical (海正药业) 2025 Annual Report Summary: Business Overview, Financial Data, and Strategic Highlights
  April 8, 2026
  

  浙江海正药业股份有限公司2025年年度报告详细解读 浙江海正药业股份有限公司2025年年度报告详细解读 一、业绩概览...

• Zhejiang Hisun Pharmaceutical Co., Ltd. 2025 Annual Report: Financial Performance, Business Overview, and Future Strategy
  April 8, 2026
  

  浙江海正药业股份有限公司2025年年度报告深度解读：业绩亮点、风险事项及投资者须知 一、业绩亮点及经营分析 营收...

🔍 View more Reports